XORTX Initiates Precision Medicine Program

MT NewswiresOct 9 18:32

XORTX Surges 62% in U.S. Premarket as Peer-Reviewed Research Backs Company's Approach to Polycystic Kidney Disease

MT NewswiresAug 29 20:09

Stocks in Play: XORTX Therapeutics Inc.

Baystreet.caMay 17 23:15

XORTX Therapeutics Reprices Warrants Connected With U.S. IPO

MT NewswiresMay 17 20:16

XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal

MT NewswiresApr 22 19:44

Press Release: XORTX Announces New Clinical Advisory Board Member

Dow JonesMar 27 17:37